BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 27174320)

  • 21. Implications of polyadenylation in health and disease.
    Curinha A; Oliveira Braz S; Pereira-Castro I; Cruz A; Moreira A
    Nucleus; 2014; 5(6):508-19. PubMed ID: 25484187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of untranslated region alternative polyadenylation in glioma tumorigenesis.
    Lan YL; Zhang J
    Biomed Pharmacother; 2021 May; 137():111416. PubMed ID: 33761620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrant Alternative Polyadenylation is Responsible for Survivin Up-regulation in Ovarian Cancer.
    He XJ; Zhang Q; Ma LP; Li N; Chang XH; Zhang YJ
    Chin Med J (Engl); 2016 May; 129(10):1140-6. PubMed ID: 27174320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.
    Hu Y; Xu K; Yagüe E
    Breast Cancer Res Treat; 2015 Jun; 151(2):269-80. PubMed ID: 25900794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression and significance of microRNAs in the p53 pathway in ovarian cancer cells and serous ovarian cancer tissues].
    Zhang Q; He XJ; Ma LP; Li N; Yang J; Cheng YX; Cui H
    Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):885-90. PubMed ID: 22340095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The microRNA target site landscape is a novel molecular feature associating alternative polyadenylation with immune evasion activity in breast cancer.
    Kim S; Bai Y; Fan Z; Diergaarde B; Tseng GC; Park HJ
    Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32844230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamics of alternative polyadenylation in human preimplantation embryos.
    Chang JY; Yu WH; Juan HF; Huang HC
    Biochem Biophys Res Commun; 2018 Oct; 504(4):727-733. PubMed ID: 30217451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genome-wide profiling of polyadenylation sites reveals a link between selective polyadenylation and cancer metastasis.
    Lai DP; Tan S; Kang YN; Wu J; Ooi HS; Chen J; Shen TT; Qi Y; Zhang X; Guo Y; Zhu T; Liu B; Shao Z; Zhao X
    Hum Mol Genet; 2015 Jun; 24(12):3410-7. PubMed ID: 25759468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The expression of HER-2/neu (c-erbB2), survivin and cycline D1 in serous ovarian neoplasms: their correlation with clinicopathological variables.
    Turan G; Usta CS; Usta A; Kanter M; Tavli L; Karacan M; Celik C; Eser M
    J Mol Histol; 2014 Dec; 45(6):679-87. PubMed ID: 25106503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survivin as a preferential target for cancer therapy.
    Mobahat M; Narendran A; Riabowol K
    Int J Mol Sci; 2014 Feb; 15(2):2494-516. PubMed ID: 24531137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The fallopian tube as the origin of high grade serous ovarian cancer: review of a paradigm shift.
    Reade CJ; McVey RM; Tone AA; Finlayson SJ; McAlpine JN; Fung-Kee-Fung M; Ferguson SE
    J Obstet Gynaecol Can; 2014 Feb; 36(2):133-140. PubMed ID: 24518912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Shortening of the 3' untranslated region: an important mechanism leading to overexpression of HMGA2 in serous ovarian cancer.
    He X; Yang J; Zhang Q; Cui H; Zhang Y
    Chin Med J (Engl); 2014; 127(3):494-9. PubMed ID: 24451956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models.
    Perets R; Wyant GA; Muto KW; Bijron JG; Poole BB; Chin KT; Chen JY; Ohman AW; Stepule CD; Kwak S; Karst AM; Hirsch MS; Setlur SR; Crum CP; Dinulescu DM; Drapkin R
    Cancer Cell; 2013 Dec; 24(6):751-65. PubMed ID: 24332043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcriptional regulation of the survivin gene.
    Boidot R; Végran F; Lizard-Nacol S
    Mol Biol Rep; 2014 Jan; 41(1):233-40. PubMed ID: 24197699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A dynamic interplay between alternative polyadenylation and microRNA regulation: implications for cancer (Review).
    An J; Zhu X; Wang H; Jin X
    Int J Oncol; 2013 Oct; 43(4):995-1001. PubMed ID: 23913120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrated analysis of microRNA and mRNA expression: adding biological significance to microRNA target predictions.
    van Iterson M; Bervoets S; de Meijer EJ; Buermans HP; 't Hoen PA; Menezes RX; Boer JM
    Nucleic Acids Res; 2013 Aug; 41(15):e146. PubMed ID: 23771142
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.